Think you need to get some perspective. Most can see it's an early stage growth company that's a little over ONE YEAR into it's listing, yet the number of contracts already achieved with large hospitals/organisations is nothing short of impressive. Despite it's achievements, it's commercialisation phase has only just begun. You only need to take a look back at the summation of the qurtrly to see the trajectory it's on.
- Calvary signing (initial beta site, then potential data lake for 15+ hospitals)
- 1.6m NZD with MDHB to be showcased to the remaining 19 other potential NZ boards
- presently working on five substantial iCVIS opportunities that are expected to close over FY18.
- Deployment of cloud based, low cost, product modules.
- Preparation for US and international expansion (uses FHIR stardard which has already been successfully integrated with Miya Platform).
-$4m in revenue FY16/$5.5 in cash ($36m MC )
- Regular updates/news flow from the company.
- Massive growth potential
If this still does not excite people, perhaps an updated broker report from NDF (from initial 20c target to something off the richter scale when now factoring all the above) will do the trick.
ALC Price at posting:
5.7¢ Sentiment: Buy Disclosure: Held
)
